Olmesartan Medoxomil / Rosuvastatin Tablets 20/20 mg
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Mothers Pharmaceuticals Co., Ltd.
MFDS item code 202003943 · Approved 2020.05.28
This product's status changed to Expired on 2025.05.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension; improvement of dyslipidemia; suppression of atherosclerosis progression and cardiovascular risk
This medication is designed for patients who require the combined use of two drugs, olmesartan medoxomil and rosuvastatin. Olmesartan medoxomil is primarily used for the treatment of essential hypertension. Meanwhile, rosuvastatin is used adjunctively when dietary measures and exercise fail to control several conditions associated with hypercholesterolemia, such as primary hypercholesterolemia, mixed dyslipidemia, and familial hypercholesterolemia. It also helps to lower cholesterol levels in patients with hypercholesterolemia, slowing the progression of atherosclerosis, and aids in the treatment of patients with dysbetalipoproteinemia. Additionally, it contributes to the reduction of stroke, myocardial infarction, and artery revascularization-related risks in elderly patients at high risk for cardiovascular disease. Therefore, this medication is used to improve both hypertension and hyperlipidemia while reducing the risk of cardiovascular diseases.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, olmesartan medoxomil and rosuvastatin. ◆ Olmesartan medoxomil 1. Adults The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at about 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that this medicine be taken at the same time each day, if possible (e.g., in the morning). For patients who may have reduced intravascular volume (e.g., patients taking diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose with close monitoring of their condition. 2. Elderly No dose adjustment is necessary when this medicine is administered to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 30-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, which may be increased to a maximum of 20mg daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients. ◆ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly No dose adjustment is necessary. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment Systemic exposure to rosuvastatin did not increase in patients with a Child-Pugh score of 7 or less, but increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 milligrams. The 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking olmesartan medoxomil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
Children under 18 years: Safety and efficacy have not been established.
This medication may cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be given to individuals with allergies to this medication or its components, pregnant or breastfeeding women, or fertile women who are not using appropriate contraception. It should not be used in patients with severely impaired kidney function, those on dialysis, patients with severe liver impairment, biliary obstruction, or those with muscular diseases. This medication contains lactose; therefore, it should not be taken by patients with lactose intolerance or related genetic disorders. Patients with low blood volume or sodium levels may experience hypotension upon initial dosing, so careful monitoring is required. Patients with severe heart failure or those whose renal function relies on the renin-angiotensin-aldosterone system should be cautious as renal function changes may occur. Due to the risk of hyperkalemia, especially in patients with heart failure or renal disease, blood potassium levels should be checked regularly. Muscle-related side effects may appear; therefore, if symptoms like myalgia or muscle weakness occur, immediate consultation with a physician is recommended. This medication can affect liver function, so it is advisable to undergo regular liver function tests before and during treatment. Dizziness or drowsiness may occur; therefore, caution is advised when driving or operating dangerous machinery. There may be drug interactions when taken in combination with other medications, so it is essential to inform your physician or pharmacist of any medications you are currently taking. Women who are pregnant or planning to become pregnant should consult their physician before taking this medication and should use appropriate contraception methods. If breastfeeding, this medication may be excreted in breast milk, so either breastfeeding needs to be discontinued or the medication should be stopped. The safety and efficacy of this medication in children under 18 years have not been established, so its use is not recommended in this age group. Elderly patients may have increased blood concentration of this medication, so dose adjustment may be necessary. In case of overdose, hypotension or cardiac arrhythmias may occur; immediate medical attention should be sought.
Elevated ALT, elevated AST, increased blood creatinine, decreased creatinine clearance, headache, dizziness, sensory impairment, neuromyopathy, drowsiness, gastroesophageal reflux disease, constipation, dental caries, dyspepsia, gastric ulcer, gastritis, gastroenteritis, musculoskeletal stiffness, atrial fibrillation, hypoglycemia, chest pain, dental extraction, chest discomfort, peripheral edema, vertigo, abdominal pain, nausea, palpitations, hypercholesterolemia, hyperlipidemia, hyperuricemia, arthralgia, arthritis, myalgia, rash, facial edema, weakness, angioedema, anaphylactic reaction, vomiting, chronic malabsorption syndrome, rhabdomyolysis, hyperkalemia, acute renal failure, hair loss, pruritus, urticaria, autoimmune hepatitis, dizziness (including positional vertigo), palpitations, increased blood pressure, low back pain, increased blood creatinine, diarrhea, cough, epistaxis, upper respiratory infection, asthma, hypersensitivity reactions including angioedema, diabetes, headache, pancreatitis, pruritus, rash and urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, dyspnea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscle weakness, ocular myasthenia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1°C and 30°C. Proper storage helps maintain the effectiveness of the medication for a longer time.
White or yellowish round film-coated tablets
30 tablets/box [30 tablets (10 tablets/Alu-Alu) × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Mothers Pharmaceuticals Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.